Breaking News

Senators reveal how much Lilly, Pfizer paid telehealth companies 

July 17, 2025
Pharmalot Columnist, Senior Writer
Sen. Dick Durbin (D-Ill.) led an inquiry into the partnerships between telehealth companies and pharma.
J. Scott Applewhite/AP

STAT+ | Senators reveal how much Lilly, Pfizer paid telehealth companies

Four senators are investigating partnerships between direct-to-consumer telehealth firms and pharma companies for possible violations of kickback laws.

By Katie Palmer


STAT+ | FDA advisers say risks of GSK blood cancer drug outweigh benefits in surprise setback

Blenrep combos have won approval in the U.K. and Japan for multiple myeloma, but FDA advisers raised concerns about eye-related side effect.

By Andrew Joseph


STAT+ | Trump's Medicare agency to speed up clawback of $7.8 billion in hospital drug payments

The plan to claw back $7.8 billion in Medicare payments to hospitals on a quicker time frame could spark legal challenges.

By Bob Herman



Adobe

Opinion: Medical research participants deserve to be paid well

There is scant empirical evidence that offers of money alone distort clinical trial participants' ability to accurately assess risk and benefits.

By Jake Eberts and Jill Fisher


STAT+ | Undruggable 'disordered' proteins become druggable with new AI techniques from David Baker

New research papers outline ways to make certain proteins more receptive to drugs, an important advance because many diseases involve disordered proteins.

By Brittany Trang


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Pharmalot? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments